The Hair Loss Encyclopedia

Search

for
Search:

Glossary

Similar Terms

Induced Pluripotent Stem Cells

Learn

0 / 0 results

— no results

Research

5 / 289 results

Androgenic Effects on Ventricular Repolarization: A Translational Study from Pharmacovigilance Databases to iPSC-Cardiomyocytes

research Androgenic Effects on Ventricular Repolarization: A Translational Study from Pharmacovigilance Databases to iPSC-Cardiomyocytes

October 2019 in “European heart journal”

Androgen-deprivation therapies increase the risk of certain heart conditions, but testosterone treatment may help.

Androgenic Effects on Ventricular Repolarization

research Androgenic Effects on Ventricular Repolarization

64 citations , August 2019 in “Circulation”

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

research Stem Cell Therapies for Epidermolysis Bullosa Treatment

22 citations , March 2023 in “Bioengineering”

Stem cell therapies may help improve symptoms and quality of life for people with epidermolysis bullosa.

Organoids in Skin Wound Healing

research Organoids in Skin Wound Healing

November 2024 in “Burns & Trauma”

Skin organoids help improve wound healing and tissue repair.

research Human Hair Follicle Pluripotent Stem Cells Promote Regeneration of Peripheral Nerve Injury: An Advantageous Alternative to ES and iPS Cells

121 citations , June 2009 in “Journal of Cellular Biochemistry”

Human hair follicle stem cells can safely and effectively help nerve regeneration.

View more "ips-cms" in research →

Community Join

3 / 3 results

community Prediction: Scube3 is never coming out

in Research/Science 6 upvotes 1 year ago

Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.

community Is there any word on when Stempsen Therapeutics and Hairclone will start phase 1 clinical trials?

in Research/Science 6 upvotes 3 years ago

Hair cloning trials by Stempsen Therapeutics and Hairclone have no updates, and it may take at least 15 years for hair cloning to be available. The conversation also mentions treatments like Minoxidil, finasteride, and RU58841.

community Dr. Tsuji and Riken to make important announcement on their hair cloning cure on Feb 10th.

in Update 57 upvotes 4 years ago

Dr. Tsuji and Riken announced a hair cloning cure with a 98.9% success rate, expected to be released in 10 years. Users expressed hope and skepticism about the affordability and timeline of the treatment.